BCDA — BioCardia Balance Sheet
0.000.00%
- $13.34m
- $10.97m
- $0.06m
Annual balance sheet for BioCardia, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 21.4 | 12.9 | 7.36 | 1.1 | 2.37 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.85 | 0.147 | 0.201 | 0.063 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 22.7 | 13.5 | 7.86 | 1.46 | 2.62 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.712 | 2.06 | 1.76 | 1.35 | 0.931 |
Other Long Term Assets | |||||
Total Assets | 23.4 | 15.7 | 9.79 | 2.99 | 3.72 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.25 | 3.71 | 3.58 | 3.61 | 2.32 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.25 | 5.34 | 4.9 | 4.59 | 2.89 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 19.2 | 10.4 | 4.89 | -1.6 | 0.837 |
Total Liabilities & Shareholders' Equity | 23.4 | 15.7 | 9.79 | 2.99 | 3.72 |
Total Common Shares Outstanding |